期刊文献+

稳定表达人MAGE-1基因小鼠黑色素瘤细胞系的建立

Establishment of mouse melanoma B16 cell lines which stably express human MAGE-1
下载PDF
导出
摘要 目的:构建真核表达载体,并在小鼠黑色素瘤B16细胞中稳定表达。方法:用PCR方法扩增质粒pUC19-MAGE-1中目的基因MAGE-1,连接到真核表达载体pCDNA3.1中,构建真核表达pCDNA3.1-MAGE-1,脂质体法转染小鼠黑色素瘤B16细胞。G418筛选阳性克隆(B16-MAGE-1),用RT-PCR和Western blot检测阳性克隆中mRNA和蛋白质的表达;分别以2×105个B16细胞和B16-MAGE-1接种于C57BL/6小鼠右侧背部皮下,观察B16-MAGE-1细胞的致瘤能力。结果:用PT-PCR与Western bolt分别在B16-MAGE-1细胞中检测到人MAGE-1基因的mNRA和蛋白质的表达,两组共20只小鼠均皮下成瘤,且肿瘤大小没有明显差异。结论:成功构建了真核表达载体pCDNA3.1-MAGE-1,获得了稳定表达人MAGE-1基因的小鼠黑色素瘤B16细胞系,并保持很好的致瘤能力,为研究MAGE家族在肿瘤免疫治疗中的应用奠定了基础。 Objective:To construct the eukaryotic expression vector which can be expressed in B16 cells. Methods: The MAGE - 1 gene was amplified by PCR from pUC19 - MAGE - 1 ,then cloned into pCDNA3.1 to construct the pCDNA3.1 - MAGE - 1 plasmid. Under the mediation of lipofectamine, the plasmid was transfected into the mouse melanoma B16 cells, and then the positive clones were selected by G418. The expression of MAGE - 1 mRNA and protein were respectively detected by RT- PCR and Western Blot. Mice (10 per group) were challenged with the B16 cells and B16 -MAGE -1 cells (2 × 10^5 cells/mouse, respectively) in the fight back. Results: The plasmid was constructed and transfected into B16 cells successfully. The expression of mRNA and protein of MAGE - 1 were approved in the positive clones, two groups both grow melanoma. Conclusion: The eukaryotic expression plasmid pCDNA3.1 - MAGE - 1 was constructed successfully. The B16 cell line that stably expressed MAGE - 1 is obtained, which will contribute to the research of MAGE family in the immunotherapy of tumor.
出处 《现代肿瘤医学》 CAS 2006年第9期1051-1053,共3页 Journal of Modern Oncology
基金 国家自然科学基金资助项目(30271464)
关键词 黑色素瘤抗原 基因转染 肿瘤免疫治疗 MAGE - 1 gene transfect immunotherapy of tumor
  • 相关文献

参考文献6

  • 1Van der Bruggen P,Traver San C,Chomez P,et al.A gene edcoding an antigen recognized by cytolytic T lymphocytes on a human melanoma[J].Science,1991,254(5038):1643 ~ 1647.
  • 2Inoue H,Mori M,Li J,et al.Human esophageal carcinomas frequently erpress the tumor-rejection antigens of MAGE genes[J].Int J Cancer,1995,63 (4):523 ~ 526.
  • 3冼磊,王俊,姜冠潮,王丹蕾,刘军,李剑锋.MAGE基因mRNA在非小细胞肺癌中的表达[J].广西医科大学学报,2005,22(1):9-12. 被引量:2
  • 4Mou DC,Cai SL,Peng JR,et al.Evaluation of MAGE-1 and MAGE -3 as tumourspecific markers to detect blood dissemination of hepatocellular carcinoma ceus[J].Br J Cancer,2002,86 (1):110 ~116.
  • 5De Plaen E,Arden K,Traversari C,et al.Strulture,chromosomal localiztation and expvession of twelve genes of the MAGE family[J].Immunogenetics,1994,40:360 ~ 369.
  • 6杨翠红,钱振超.人类黑色素瘤抗原的研究进展[J].国外医学(免疫学分册),1998,21(2):68-71. 被引量:6

二级参考文献12

  • 1Lucas S, De Smet C, Arden KC, et al. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res, 1998,58(2):743-752.
  • 2Li J, Yang Y, Fujie T, et al. Expression of MAGE gene family in human gastric carcinoma. Anticancer Res,1997,17(5A):3 559-3 563.
  • 3D'Cunha J,Corfits AL,Herndon JE 2nd,et al. Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer:preliminary results of Cancer and Leukemia Group B Trial 9 761. J Thorac Cardiovasc Surg, 2002,123(3):484-491.
  • 4Mountain CF. Revisions in international system for staging lung cancer. Chest,1997,111(6):1 710-1 717.
  • 5Salerno CT, Frizelle S, Niehans GA, et al. Detection of occult micrometastasis in non-small cell lung carcinoma by reverse transcriptase-polymerase chain reaction.Chest,1998,113(6):1 526-1 532.
  • 6Quillien V, Raoul JL, Heresbach D, et al. Expression of MAGE genes in esophageal squamous cell carcinoma.Anticancer Res, 1997,17 (1A) : 387-391.
  • 7Yoshimatsu T, Yoshino I, Ohgami A, et al. Expression of the melanoma antigen-encoding gene in human lung cancer. J SurgOncol, 1998,67(2):126-129.
  • 8Tahara K,Mori M ,Sadanaga N ,et al. Expression of MAGE gene family in human hepatocellular carcinoma.Cancer,1999,15(6):1 234-1 240.
  • 9Fujie T,Tahara K,Tanaka F,et al. A MAGE-1-encoded HLA-A24-binding synthetic peptide induces specific antitu-morcytotoxic T lymphocytes. Int J Cancer, 1999, 80(2):169-172.
  • 10JF Toso, C Oei, F Oshidari, et al. MAGE-1 specific precursor cytotoxic T lymphocytes from a patient with breast cancer: characterization and antigen-specific activation. Cancer Res, 1996 (1), 56:16-20.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部